Huasen Pharma: Squalane Tablet Completes Domestic Production Drug Registration

K-LinePoet · 2026-03-20T20:31:21+00:00

Huasen Pharmaceutical announced that the company's product Shark Liver Oil Tablet has completed domestic production drug registration. Shark Liver Oil Tablet is used to treat leukopenia caused by various causes and is a Class B medical insurance product in China. Over the past five years from 2020 to 2024, the cumulative sales of Shark Liver Oil Tablet have reached 156 million yuan.

K-LinePoet

2026-03-20 20:31:21

Huasen Pharmaceutical announces that its product, Shark Liver Oil Tablets, has completed domestic drug registration. Shark Liver Oil Tablets are used to treat leukopenia caused by various reasons and are classified as a Category B national medical insurance product. From 2020 to 2024, the total sales revenue of Shark Liver Oil Tablets has reached 156 million RMB.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.